Connect with us

European Commission

EU funds further strategic reserves for medical, chemical, biological and radio-nuclear emergencies worth €690 million

SHARE:

Published

2 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

The Commission is allocating around €690 million to Czechia, Finland, France, Lithuania, Poland, Portugal and Romania to further develop the rescEU strategic reserves of medical and chemical, biological, radiological and nuclear (CBRN) items. The reserves are part of the EU Civil Protection Mechanism's rescEU medical stocks funded by the Health Emergency Preparedness and Response Authority (HERA). This new funding brings the number of rescEU hosting countries to 16, with 21 medical or CBRN reserves, strategically distributed across the EU.

These stocks encompass countermeasures that pose a significant risk of rapid depletion or increased demand during crisis scenarios, including:

Therapeutics such as intensive care medicines, antibiotics, vaccines, antidotes, medical devices, personal protective equipment and items to respond to chemical, biological, radiological and nuclear events.

These grants to member states aim to greatly enhance the quality and quantity of the reserves' composition for different crisis situations and addressing the long-term sustainability of the stocks.

The new funding builds on existing reserves already set up in Croatia, France, Poland and Finland.

The press release is available online.

Advertisement

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending